Process for the production of monoclonal antibodies
AssigneeBiotechnologijos Institutas
InventorsAurelija Zvirbliene, Alma Gedvilaite, Rainer Ulrich, Kestutis Sasnauskas
Life of this patent
Estimating the term…
Abstract
Provided is a use of a recombinant chimaeric protein as an immunogen in a process for producing a monoclonal antibody, wherein the recombinant chimaeric protein is assembled into a virus-like particles, and includes a foreign protein or peptide or a fragment thereof.
Claims18
A method for producing a hybridoma capable of producing a monoclonal antibody against a foreign protein or peptide, comprising the steps of:
- a) immunizing a non-human animal;
- b) harvesting spleen cells from the immunized animal;
- and
- c) hybridising the harvested spleen cells to immortalised cells to obtain a hybridoma;
- wherein the immunization of the non-human animal is performed with a recombinant chimaeric protein which is assembled into a virus-like particle, which includes the foreign protein or peptide or a fragment thereof and which comprises at least a part of a hamster polyoma virus capsid protein sequence.
A method for producing a monoclonal antibody against a foreign protein or peptide, comprising the steps of:
- a) immunizing a non-human animal;
- b) harvesting spleen cells from the immunized animal;
- c) hybridising the harvested spleen cells to immortalised cells to obtain a hybridoma;
- d) propagating the hybridoma;
- and
- e) obtaining the antibody from the hybridoma
- wherein the immunization of the non-human animal is performed with a recombinant chimaeric protein which is assembled into a virus-like particle, which includes the foreign protein or peptide or a fragment thereof and which comprises at least a part of a hamster polyoma virus capsid protein sequence.
A method for obtaining an isolated monoclonal antibody against a foreign protein or peptide, comprising the step of immunizing a non-human animal with a recombinant chimaeric protein wherein the recombinant chimaeric protein is assembled into a virus-like particle, includes a foreign protein or peptide or a fragment thereof, and comprises at least a part of a hamster polyoma virus capsid protein sequence.
A method for producing a hybridoma capable of producing a monoclonal antibody against a foreign protein or peptide, comprising the steps of:
- a) immunizing a non-human animal;
- b) harvesting spleen cells from the immunized animal;
- and
- c) hybridising the harvested spleen cells to immortalised cells to obtain a hybridoma;
- wherein the immunization of the non-human animal is performed with a recombinant chimaeric protein which is assembled into a virus-like particle, which includes the foreign protein or peptide or a fragment thereof and which comprises at least a part of a hamster polyoma virus major capsid protein VP1.
A method for producing a monoclonal antibody against a foreign protein or peptide, comprising the steps of:
- a) immunizing a non-human animal;
- b) harvesting spleen cells from the immunized animal;
- c) hybridising the harvested spleen cells to immortalised cells to obtain a hybridoma;
- d) propagating the hybridoma;
- and
- e) obtaining the antibody from the hybridoma
- wherein the immunization of the non-human animal is performed with a recombinant chimaeric protein which is assembled into a virus-like particle, which includes the foreign protein or peptide or a fragment thereof and which comprises at least a part of a hamster polyoma virus major capsid protein VP1.
An antibody which binds to human mucin at an epitope within SEQ ID No. 2
Dependencies are inferred from the claim text.